clinical trial · NCT06889805
HDV Screening Study
Grace Lai Hung Wong·—·recruiting·n = 300
Hepatitis D Virus Infection
brief summary
This is a territory-wide cross-sectional study of all individuals living with HIV/HBV coinfection and HBV-related HCC.
started
Feb 15, 2025
primary completion
Aug 17, 2028
completion
Feb 17, 2029
last updated
Mar 24, 2025
detailed description
Chronic hepatitis B virus (HBV) infection remains endemic in Hong Kong with an estimated prevalence of 6.2% in the recent Population Health Survey 2020-2022.1 The estimated prevalence of chronic HBV infection among individuals living with HIV is 8%.2 Yet, no data are available concerning the disease burden of hepatitis delta virus (HDV) among individuals living with HIV/HBV coinfection.
official title
Universal Screening for Hepatitis Delta Virus (HDV) in Individuals Living with HIV/HBV Coinfection and HBV-related HCC
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol